Show
Sort by
-
ST2 as checkpoint target for colorectal cancer immunotherapy
-
Dendritic cell targeting mRNA lipopolyplexes combine strong antitumor T-cell immunity with improved inflammatory safety
-
Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma
-
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells
-
Intratumoral delivery of mRNA : overcoming obstacles for effective immunotherapy
-
- Journal Article
- A1
- open access
Targeting the tumor microenvironment to enhance antitumor immune responses